Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001831942-25-000021·Commodore Capital LP
Schedule 13G ownership disclosure
Palisade Bio, Inc.
Common Stock, par value $0.01 per share · CUSIP: 696389402
Event date: 2025-10-01
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Commodore Capital LP
Shares: 9,690,665.00 · Class: 9.9%
- Commodore Capital Master LP
Shares: 9,690,665.00 · Class: 9.9%
- Robert Egen Atkinson
Shares: 9,690,665.00 · Class: 9.9%
- Michael Kramarz
Shares: 9,690,665.00 · Class: 9.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001831942-25-000021
- Form type
- SCHEDULE 13G
- Filer
- Commodore Capital LP
- CIK
- CIK 1831942
- Filed
- Oct 08, 2025
- Reporting period
- Oct 01, 2025
- Description
- Schedule 13G beneficial ownership